ATE397600T1 - Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungen - Google Patents
Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungenInfo
- Publication number
- ATE397600T1 ATE397600T1 AT05737841T AT05737841T ATE397600T1 AT E397600 T1 ATE397600 T1 AT E397600T1 AT 05737841 T AT05737841 T AT 05737841T AT 05737841 T AT05737841 T AT 05737841T AT E397600 T1 ATE397600 T1 AT E397600T1
- Authority
- AT
- Austria
- Prior art keywords
- methyl
- synthesis process
- production
- sub
- imidazole compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04076319 | 2004-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE397600T1 true ATE397600T1 (de) | 2008-06-15 |
Family
ID=34966069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05737841T ATE397600T1 (de) | 2004-05-03 | 2005-04-28 | Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7456287B2 (de) |
| EP (1) | EP1751137B1 (de) |
| JP (1) | JP5008554B2 (de) |
| CN (1) | CN100567292C (de) |
| AT (1) | ATE397600T1 (de) |
| AU (1) | AU2005238223B2 (de) |
| CA (1) | CA2563807C (de) |
| DE (1) | DE602005007346D1 (de) |
| ES (1) | ES2308486T3 (de) |
| HK (1) | HK1101580A1 (de) |
| WO (1) | WO2005105784A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3385395B9 (de) | 2015-08-17 | 2020-05-20 | Kura Oncology, Inc. | Verfahren zur behandlung von krebspatienten mit farnesyl-transferase-inhibitoren |
| WO2018085518A2 (en) | 2016-11-03 | 2018-05-11 | Kura Oncology, Inc. | Methods of treating cancer patients with farnesyltransferase inhibitors |
| US10954210B2 (en) | 2016-12-08 | 2021-03-23 | Hangzhou Solipharma Co., Ltd. | Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof |
| CA3100706A1 (en) * | 2018-05-18 | 2019-11-21 | Kura Oncology, Inc. | Synthesis of tipifarnib |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE321757T1 (de) | 1995-12-08 | 2006-04-15 | Janssen Pharmaceutica Nv | (imidazol-5-yl)methyl-2-chinolinonderivate als farnesyl protein transferase inhibitoren |
| HN2000000266A (es) * | 2000-01-21 | 2001-05-21 | Pfizer Prod Inc | Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto. |
| PL208238B1 (pl) | 2001-03-12 | 2011-04-29 | Janssen Pharmaceutica Nv | Sposób wytwarzania 4- (3-chlorofenylo) -6- [ (4-chlorofenylo) hydroksy (1-metylo-1H-imidazol-5-ilo) metylo] -1-metylo-2 (1H) -chinolinonu |
| AU2003241747A1 (en) * | 2002-06-11 | 2003-12-22 | Kaneka Corporation | PROCESS FOR PRODUCING OPTICALLY ACTIVE ss-AMINO ALCOHOL |
-
2005
- 2005-04-28 ES ES05737841T patent/ES2308486T3/es active Active
- 2005-04-28 US US11/568,426 patent/US7456287B2/en active Active
- 2005-04-28 DE DE602005007346T patent/DE602005007346D1/de active Active
- 2005-04-28 JP JP2007512170A patent/JP5008554B2/ja active Active
- 2005-04-28 AT AT05737841T patent/ATE397600T1/de not_active IP Right Cessation
- 2005-04-28 AU AU2005238223A patent/AU2005238223B2/en active Active
- 2005-04-28 CN CNB2005800133182A patent/CN100567292C/zh active Active
- 2005-04-28 WO PCT/EP2005/051934 patent/WO2005105784A1/en active IP Right Grant
- 2005-04-28 EP EP05737841A patent/EP1751137B1/de active Active
- 2005-04-28 CA CA2563807A patent/CA2563807C/en active Active
-
2007
- 2007-08-28 HK HK07109363.3A patent/HK1101580A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7456287B2 (en) | 2008-11-25 |
| ES2308486T3 (es) | 2008-12-01 |
| AU2005238223A1 (en) | 2005-11-10 |
| HK1101580A1 (en) | 2007-10-18 |
| EP1751137B1 (de) | 2008-06-04 |
| DE602005007346D1 (de) | 2008-07-17 |
| CA2563807A1 (en) | 2005-11-10 |
| CA2563807C (en) | 2012-11-20 |
| CN100567292C (zh) | 2009-12-09 |
| US20070238880A1 (en) | 2007-10-11 |
| JP2007536335A (ja) | 2007-12-13 |
| WO2005105784A1 (en) | 2005-11-10 |
| EP1751137A1 (de) | 2007-02-14 |
| JP5008554B2 (ja) | 2012-08-22 |
| CN1946711A (zh) | 2007-04-11 |
| AU2005238223B2 (en) | 2012-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1713475T3 (da) | 1,3,5-trisubstituerede 4,5-dihydro-1H-pyrazol-derivater med CB1-antagonistisk aktivitet | |
| AU2018260844A1 (en) | Processes of making and crystalline forms of a MDM2 inhibitor | |
| WO2005070890A3 (en) | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof | |
| EA200800728A1 (ru) | Полиморфы бензоатной соли 2-[[6-[(3r)-3-амино-1-пиперидинил]-3,4-дигидро-3-метил-2,4-диоксо-1(2н)-пиримидинил]метил]бензонитрила и способы их применения | |
| RS53684B1 (en) | PROSTACYCLINE (PGI2) MODULATORS FOR RECIPES USEFUL IN TREATMENT OF PGI2-related DISORDERS | |
| EA200870336A1 (ru) | Полициклические производные циннамида | |
| RS54199B1 (en) | PROCEDURE FOR OBTAINING INTERMEDIERS OF USEFUL USES AS OPIOID RECEPTOR MODULATORS | |
| RS54030B1 (en) | PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT | |
| SG170729A1 (en) | Processes and intermediates for preparing steric compounds | |
| RU2007147955A (ru) | Способ получения дигидрохиназолинов | |
| WO2008032338A3 (en) | Improved process for the preparation of ezetimibe and its intermediates | |
| ATE397600T1 (de) | Diastereoselektives syntheseverfahren zur herstellung vn imidazolverbindungen | |
| EA201100696A1 (ru) | 1-(арилсульфонил)-4-(пиперазин-1-ил)-1h-бензимидазолы в качестве лигандов 5-гидрокситриптамина-6 | |
| DE602006014022D1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
| WO2008014360A3 (en) | Modulators of chemokine receptor activity, crystalline forms and process | |
| NO20071817L (no) | Fremgangsmate for a fremstille enantiomeriske imidazolforbindelser | |
| MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
| ATE398612T1 (de) | Diastereoselektive addition von lithiiertem n- methylimidazol an sulfinimine | |
| TW200612944A (en) | 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors | |
| EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
| MX2007000906A (es) | Procedimiento para la preparacion de 3-(4-piperidinil) -2, 3, 4, 5-tetrahidro-1, 3-benzodiazepin -2(1h)-ona. | |
| DE602004031878D1 (de) | Immunhemmende pyrazolon-verbindungen | |
| WO2010049952A3 (en) | A novel process for the preparation of eletriptan | |
| SE0400410D0 (sv) | New compounds | |
| ATE549331T1 (de) | Sulfoximinderivate asp38-map-kinase-inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |